Each week,aprofessional investor tells MoneyWeek where she'd put her money now. This week: Rebecca O'Keeffe, head of investment at Interactive Investor.
From stagnant global manufacturing and sliding commodity prices to Federal Reserve interest-rate hikes, the macroeconomic landscape remains tricky for investors to navigate. However, I remain relatively optimistic on prospects for equities over the coming months, not least because the stockmarket is relatively unloved. Rallies typically come to an end when everyone is fully invested, and as a result there is limited scope for further purchases. Today, many investors are still sitting in cash on the sidelines, suggesting that there is plenty of scope for prices to rise further.
On top of that, history suggests that investing over the winter tends to be more favourable than in the summer between 1 November and 30 April, stocks tend to be less volatile, sentiment more positive, liquidity is strong and hence performance versus the rest of the year is, on average, better in risk-adjusted and absolute terms. Taking this into account, I have a preference at this time of year for high-beta (ie, risky) ideas.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
My first choice is the Axa FramlingtonBiotech fund (Axa-IM.co.uk). The biotech sector as a whole is down nearly 20% sinceits July highs. Yet an ageing population, combined with rapid advances in science, including genome sequencing and personalised medicine, make this ever-expanding industry attractive over the long run, and this fund has a good track record. With more than 85% exposure to US equities, Axa's fund is inevitably exposed to wider sentiment affecting the region, including the impact of a stronger dollar as the Fed starts to hike rates.
My second investment is based on the theory that, in a world that is gradually moving beyond the global financial crisis, investors can benefit from investing in countries in which the political backdrop is improving. In India, Narendra Modi has now been in power for18 months. He has worked hard to introduce a raft of pro-business policies aimed at boosting economic growth. After a strong rally in 2014, the Indian equity market slipped back in 2015 as investors became frustrated at the perceived lack of progress. But given the labyrinthine complexity of India's bureaucracy, this judgment is probably premature. With Modi's reform policies gradually taking effect, and aided by the sharp fall in energy prices over the past year, there is scope for India's economy to outperform significantly in 2016. Several India funds are available, including options from Jupiter, Kotak, Franklin and Fidelity.
My final investment choice is the River & Mercantile UK Smaller Companiesfund (RiverandMercantile.com). Chancellor George Osborne's recent Autumn Statement was very positive towards small and mid-cap businesses, and by making buy-to-let mortgages less attractive has raised the prospect of money being invested in equities instead. Over the past year, UK small-cap stocks have significantly outperformed their large-cap counterparts, which are much more exposed to global growth concerns. Despite this outperformance, I still think small caps offer good prospects over the next few months as money flows into the smaller companies sector via venture capital trusts and other tax-efficient products. River & Mercantile's fund consistently delivers solid performance.
My choices deliberately look at long-term trends in combination with short-term opportunities. They are definitely not low risk and won't appeal to everyone. But while it is vital to be able to sleep well at night, taking too little risk can be as much of a threat to your wealth as taking too much, assuming your investment horizon is sufficiently long.
-
Water companies blocked from using customer money to pay “undeserved” bonusesThe regulator has blocked three water companies from using billpayer money to pay £1.5 million in exec bonuses
-
Will the Bitcoin price hit $100,000?With Bitcoin prices trading just below $100,000, we explore whether the cryptocurrency can hit the milestone.
-
Somero: trading this overlooked bargainFeatures Mechanical-screed maker Somero dominates its niche and is attractively valued. Matthew Partridge picks the best way to trade it.
-
How to find big profits in small companiesCover Story The small- and micro-cap sectors are risky and volatile. But with careful research and patience, investors could make huge gains. Matthew Partridge explains how to find the market’s top tiddlers.
-
The hidden gems on Aim, London's junior marketFeatures Aim, London’s junior market, is risky – but you can find solid stocks at low prices. Scott Longley reports.
-
Is Aim finally coming of age?Features The Aim market of mostly smaller companies has traditionally been seen as a bit of a backwater. Is it time to change that view? Matthew Partridge talks to Paul Latham and Richard Power of fund management company Octopus.
-
Fetch! The Chinese small-cap stocks to buy in the Year of the DogOpinion Each week, a professional investor tells us where she’d put her money. This week: Tiffany Hsiao of Matthews Asia selects three Chinese small-cap stocks with exciting potential.
-
Small and mid-cap stocks with big potential
Opinion Professional investor Guy Anderson of the Mercantile Investment Trust selects three small and medium-sized firms with promising prospects that the market has missed.
-
Get cheap, reliable growth from smaller companiesFeatures One of the most reliable long-term investment trends is the long-term outperformance of smaller companies over blue chips. Max King picks some of the best ways to buy into this growth.
-
Big gains from small caps
Features In an environment of middling inflation and low interest rates, small-cap stocks tend to beat big blue-chips. John Stepek explains why, and how to invest in them.
